Franco Locatelli, MD, PhD¹, Michael B. Jordan, MD^2,3, Carl Allen^4*, Simone Cesaro, MD^5*, Carmelo Rizzari^6*, Anupama Rao^7*, Barbara Degar, MD^8*, Tim Garrington, MD^9*, Julian Sevilla, MD, PhD^10*, Maria Caterina Putti, MD^11*, Franca Fagioli, MD^12*, Martina Ahlmann, MD^13*, Jose-Luis Dapena Diaz^14*, Michael Henry, MD^15*, Fabrizio De Benedetti, MD^16*, Alexei Grom^17*, Anna Stoltenberg^18*, Mårten Vågerö^18* and Cristina de Min^19*

¹The Department of Pediatrics, Sapienza, University of Rome, and the Department of Pediatric Hematology–Oncology, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
²University of Cincinnati College of Medicine, Cincinnati, OH
³Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁴Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX
⁵The Pediatric Hematology–Oncology, Woman and Child Hospital, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
⁶The Pediatric Hematology–Oncology Unit, Department of Pediatrics, University of Milano–Bicocca, Monza Brianza per il Bambino e la sua Mamma Foundation, Monza, Italy
⁷Department of Hematology, Great Ormond Street Hospital for Children, London, United Kingdom
⁸Department of Pediatric Hematology–Oncology, Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
⁹The Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
¹⁰The Departments of Pediatric Hematology–Oncology and Hematology and Oncology, Fundación para la Investigación Biomédica, Hospital Infantil Universitario Niño Jesús, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain
¹¹The Clinic of Pediatric Hematology–Oncology, University Hospital of Padova, Padua, Italy
¹²The Division of Pediatric Onco-Hematology, Regina Margherita Hospital, Turin, Italy
¹³Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
¹⁴Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
¹⁵The Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
¹⁶Division of Rheumatology, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
¹⁷The Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
¹⁸Swedish Orphan Biovitrum (Sobi) AB, Stockholm, Sweden
¹⁹Swedish Orphan Biovitrum (Sobi) AG, Basel, Switzerland

Jae H. Park, MD¹, Nitin Jain, MD², Andy Chen, MD, PhD³, Joseph P. McGuirk, DO⁴, Monica Diaz^5*, Bahram Valamehr, PhD⁶, Yu-Waye Chu, MD⁶ and Januario E. Castro, MD⁷

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
³OHSU - Hematologic Malignancies, Portland, OR
⁴Department of Blood and Bone Marrow Transplant, The University of Kansas Medical Center, Kansas City, KS
⁵Fate Therapeutics Inc., San Diego, CA
⁶Fate Therapeutics, Inc., San Diego, CA
⁷Mayo Clinic, Phoenix, AZ

David H. Quach, PhD^*, Haran R. Ganesh, BS^*, Sachin Thakkar, PhD^*, Luis Becerra-Dominguez, BS^*, Birju Mehta, MS^*, Silvana Perconti, MS^*, Eric Anderson, BS^*, Emily M. Hsieh, MD^*, Olga Dakhova, MD^*, Huimin Zhang, BS^*, Bambi J. Grilley, RPh^*, Malcolm K. Brenner, MD, PhD^*, Helen E. Heslop, MD, DSc, Carlos A. Ramos, MD, Rayne H. Rouce, MD, Natalia Lapteva, PhD^* and Cliona M. Rooney, PhD^*

Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX

Martin Hutchings, MD, PhD^1*, Fritz Offner, MD, PhD², Francesc Bosch, MD, PhD³, Giuseppe Gritti, MD, PhD^4*, Carmelo Carlo-Stella, MD⁵, Harriet Walter^6*, William Townsend, MRCP, MD, FRCPath^7*, Franck Morschhauser, MD, PhD^8*, Guillaume Cartron, MD, PhD^9*, Hervé Ghesquieres, MD, PhD^10*, Sophie de Guibert, MD^11*, Sylvia Herter, PhD^12*, Koorosh Korfi, PhD^13*, Veronica Craine^14*, Sarah Louise Mycroft^15*, Matt Whayman^15*, Claudia Mueller^16*, Natalie Dimier, PhD^15*, Tom Moore, MBChB^17*, Sara Belli^18*, Martin Kornacker, MD¹⁸, Katharina Lechner^16* and Michael Dickinson, MBBS, FRACP, FRCPA¹⁹

¹Department of Hematology; Finsen Centre, National Hospital, Copenhagen University Hospital, Copenhagen, Denmark
²University Hospital Ghent, Gent, Belgium
³Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
⁴ASST Papa Giovanni XXIII, Bergamo, Italy
⁵Humanitas Clinical and Research Center, and Humanitas University, Milan, Italy
⁶6The HOPE Clinical Trials Unit, Leicester, United Kingdom
⁷King's College, London - Rayne Institute, London, United Kingdom
⁸Department of Hematology, Centre Hospitalier Régional Universitaire De Lille, Lille, France
⁹Centre Hospitalier Universitaire de Montpellier, Montpellier, France
¹⁰Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
¹¹Centre Hospitalier Universitaire, Rennes, France
¹²Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland
¹³A4P Consulting Ltd, Sandwich, United Kingdom
¹⁴Hoffmann-La Roche Limited, Mississauga, Canada
¹⁵Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United Kingdom
¹⁶Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany
¹⁷Roche Innovation Center Munich, Roche Pharma Research and Early Development, Munich, Germany
¹⁸Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
¹⁹Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Hema Dave, MD, MPH¹, Mimi Mai^2*, Madeline Terpilowski, BS^2*, Keri Toner, MD¹, Maja Stanojevic, MD^2*, Morgan Galligan, BS^2*, Abeer Shibli, BS^2*, Melanie Grant, PhD^2*, Christopher Lazarski, PhD^2*, Philip Y Maglo, BS, MPH^2*, Nan Zhang^2*, Jay Tanna, MS^2*, Richard F. Ambinder, MD³, Martha Glenn, MD⁴, Patrick Hanley, PhD^2* and Catherine M. Bollard, MD, MBChB¹

¹Children's National Hospital and The George Washington University, Washington, DC
²Program for Cell Enhancement and Technologies for Immunotherapy (CETI), Children's National Hospital, Washington, DC
³Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD
⁴Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT

Benjamin K Elstrott, BA^1*, Sarah J. Nagle, MD², Caleb Price, BS^1*, Luz Mejia-Flores^3*, Nathan Beird^3* and H. E. Hinson, MD, MCR^1*

¹Oregon Health & Science University, Portland, OR
²Knight Cancer Institute, Oregon Health and Science University, Portland, OR
³Portland State University, Portland, OR

Sanaz Ghafouri, MD¹, Christopher Walthers, PhD^2*, Mobina Roshandell, MS^2*, Brenda Ji, BS^2*, Jacqueline Trent^2*, Jia Ming Chen, PhD^2*, Jacob Naparstek^2*, Monica Mead, MD, BS³, John M. Timmerman, MD⁴, Yvonne Chen^5* and Sarah Larson, MD⁶

¹Department of Hematology and Oncology, University of California Los Angeles, Saratoga, CA
²UCLA, los angeles, CA
³Department of Hematology/Oncology, UCLA Medical Center, Santa Monica, CA
⁴Division of Hematology & Oncology, UCLA Medical Center, Los Angeles, CA
⁵University of California Los Angeles, Los Angeles, CA
⁶UCLA, Santa Monica, CA

Christian Laveille^1*, Philippe Jacqmin^2*, Kathy de Graaf^3* and Cristina de Min^4*

¹Calvagone Sarl, Liergues, France
²MnS Modelling and Simulation, Dinant, Belgium
³Affimed GmbH, Heidelberg, Germany
⁴Swedish Orphan Biovitrum (Sobi) AG, Basel, Switzerland

Lorna Neill^1*, Strachan C Mackenzie, MBBS, BSc, MRCP^1*, Maria A V Marzolini^1*, William Townsend, MRCP, MD, FRCPath^1*, Kirit M. Ardeshna¹, Kate Cwynarski^1*, Surjo De^2*, Vanya Gant^2*, Lhara Mure^1*, Sara McElduff^1*, Chantelle Hughes^1*, Karl S Peggs, MD, PhD^3*, Claire Roddie, PhD, MD^4* and Maeve A O'Reilly, MBBCHBAO¹

¹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Department of Microbiology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³University College London Cancer Institute, UCL Cancer Institute, London, United Kingdom
⁴Department of Haematology, Clinical Lead, CAR-T, University College London Hospitals Senior Lecturer in Haematology, University College London NHS Foundation Trust, London, United Kingdom

Savita Dandapani, MD, PhD^1*, Geoffrey Shouse, DO, PhD², Jekwon Yeh, MD^1*, Thai Cao, MD^3*, Jeffrey Wong, MD^4* and Lihua E Budde, MD, PhD⁵

¹City of Hope National Medical Center, Duarte, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
³Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁴Department of Radiation Oncology, City of Hope, Duarte, CA
⁵T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Joseph Rimando, MD¹, Michael P. Rettig, PhD², Matt Christopher, MD, PhD³, Julie K Ritchey^4*, Miriam Y Kim, MD⁵, John Muth, MS^6*, Jan Davidson^6* and John F. DiPersio, MD³

¹Department of Medicine, Washington University School of Medicine, St. Louis, MO
²Department of Internal Medicine, Division of Oncology, Washington Univ. School of Med., Saint Louis, MO
³Washington University School of Medicine, Saint Louis, MO
⁴Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁵Washington University in St Louis, Saint Louis, MO
⁶MacroGenics, Inc., Rockville, MD

Staffan Holmberg-Thydén, MD^1,2*, Inge Høgh Dufva, MD, PhD^3*, Anne Ortved Gang, MD, PhD^4,5*, Marie Fredslund Breinholt, MD^6*, Lone Schejbel, PhD^7*, Mette Klarskov Andersen, MD, DMSc^8,9, Mohammad Kadivar, PhD^1*, Inge Marie Svane, Prof, MD, PhD^4,10,11*, Kirsten Grønbæk, Prof, MD, DMSc^12,13, Sine Reker Hadrup, Prof^1* and Daniel El Fassi, MD, PhD^4,5*

¹T-cells and cancer, Technical University of Denmark, Health technology, Kgs. Lyngby, Denmark
²Dept. of Hematology, Herlev Hospital, Copenhagen SV, Denmark
³Dept. of Palliative oncology, North Zealand hospital, Hillerød, Denmark
⁴Dept. of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
⁵Dept. of Hematology, Herlev Hospital, Herlev, Denmark
⁶Dept. of Pathology, Herlev Hospital, Herlev, CA, Denmark
⁷Dept. of Pathology, Herlev Hospital, Herlev, Denmark
⁸The Chromosome Laboratory, Copenhagen, Denmark
⁹Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
¹⁰Dept. of Oncology, Herlev Hospital, Herlev, Denmark
¹¹National Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark
¹²Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
¹³The Epi-/Genome Laboratory, Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Franco Locatelli, MD, PhD^1,2, Michael B. Jordan, MD^3,4, Carl Allen^5*, Simone Cesaro, MD^6*, Carmelo Rizzari^7*, Anupama Rao^8*, Barbara Degar, MD^9*, Tim Garrington, MD^10*, Julian Sevilla, MD, PhD^11*, Maria Caterina Putti, MD^12*, Franca Fagioli, MD^13*, Martina Ahlmann, MD^14*, Jose-Luis Dapena Diaz^15*, Michael Henry, MD^16*, Fabrizio De Benedetti, MD^17*, Alexei Grom^18* and Cristina de Min^19*

¹Department of Pediatrics, University of Rome Sapienza, Rome, Italy
²Department of Pediatric Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
³Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁴University of Cincinnati College of Medicine, Cincinnati, OH
⁵Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX
⁶The Pediatric Hematology–Oncology, Woman and Child Hospital, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
⁷The Pediatric Hematology–Oncology Unit, Department of Pediatrics, University of Milano–Bicocca, Monza Brianza per il Bambino e la sua Mamma Foundation, Monza, Italy
⁸Department of Hematology, Great Ormond Street Hospital for Children, London, United Kingdom
⁹Department of Pediatric Hematology–Oncology, Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
¹⁰The Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
¹¹The Departments of Pediatric Hematology–Oncology and Hematology and Oncology, Fundación para la Investigación Biomédica, Hospital Infantil Universitario Niño Jesús, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain
¹²The Clinic of Pediatric Hematology–Oncology, University Hospital of Padova, Padua, Italy
¹³The Division of Pediatric Onco-Hematology, Regina Margherita Hospital, Turin, Italy
¹⁴Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
¹⁵Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
¹⁶The Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
¹⁷Division of Rheumatology, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
¹⁸The Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
¹⁹Swedish Orphan Biovitrum (Sobi) AG, Basel, Switzerland